Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
John D Sheppard1,2 1Virginia Eye Consultants, 2Department of Ophthalmology, Eastern Virginia Medical School, Norfolk, VA, US Abstract: Topical nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, alone or in combination, have historically been used off label in the US to prevent and...
Enregistré dans:
Auteur principal: | Sheppard JD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5bc260cfa78e4aaead5935d2ffd2a3dd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
par: Palacio C, et autres
Publié: (2016) -
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
par: Javier Obis, et autres
Publié: (2021) -
Pseudophakic cystoid macular edema: update 2016
par: Grzybowski A, et autres
Publié: (2016) -
A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
par: Hosseini K, et autres
Publié: (2016) -
Treatment costs of cystoid macular edema among patients following cataract surgery
par: Schmier JK, et autres
Publié: (2016)